{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:20:19Z","timestamp":1774506019958,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ajog.2014.07.007","type":"journal-article","created":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T04:49:11Z","timestamp":1405054151000},"page":"561.e1-561.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Sacral nerve stimulation reduces elevated urinary nerve growth factor levels in women with symptomatic detrusor overactivity"],"prefix":"10.1016","volume":"211","author":[{"given":"Dara Faye","family":"Shalom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmala","family":"Pillalamarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangying","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence Russell","family":"Lind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey Allen","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2537-8512","authenticated-orcid":false,"given":"Christine Noel","family":"Metz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2014.07.007_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2165\/00019053-200725020-00005","article-title":"Disease burden of overactive bladder: quality-of-life data assessed using ICI-recommended instruments","volume":"25","author":"Basra","year":"2007","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ajog.2014.07.007_bib2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1185\/03007990902791025","article-title":"Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage","volume":"25","author":"Cisternas","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ajog.2014.07.007_bib3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0929-6646(10)60133-7","article-title":"Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders","volume":"109","author":"Liu","year":"2010","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.ajog.2014.07.007_bib4","first-page":"e69","article-title":"Can urinary nerve growth factor be a biomarker for overactive bladder?","volume":"12","author":"Kuo","year":"2010","journal-title":"Rev Urol"},{"key":"10.1016\/j.ajog.2014.07.007_bib5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1464-410X.2010.09585.x","article-title":"Urinary nerve growth factor in women with overactive bladder syndrome","volume":"107","author":"Liu","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.ajog.2014.07.007_bib6","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1464-410X.2009.08380.x","article-title":"Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder","volume":"103","author":"Liu","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.ajog.2014.07.007_bib7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.eururo.2008.04.037","article-title":"Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection","volume":"56","author":"Liu","year":"2009","journal-title":"Eur Urology"},{"key":"10.1016\/j.ajog.2014.07.007_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0090-4295(99)80384-7","article-title":"Quality of life of persons with urinary incontinence: development of a new measure","volume":"47","author":"Wagner","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.ajog.2014.07.007_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/nau.1930140206","article-title":"Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group","volume":"14","author":"Uebersax","year":"1995","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ajog.2014.07.007_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0090-4295(96)00506-7","article-title":"Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant","volume":"49","author":"Janknegt","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.ajog.2014.07.007_bib11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1464-410X.2012.11672.x","article-title":"Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?","volume":"111","author":"Seth","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.ajog.2014.07.007_bib12","first-page":"2341","article-title":"Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity","volume":"175","author":"Giannantoni","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ajog.2014.07.007_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00192-012-1854-4","article-title":"Changes in urinary nerve growth factor and prostaglandin E2 in women with overactive bladder after anticholinergics","volume":"24","author":"Cho","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.ajog.2014.07.007_bib14","first-page":"1005","article-title":"Sacral neuromodulation in women with idiopathic detrusor overactivity incontinence: decreased overactivity but unchanged bladder contraction strength and urethral resistance during voiding","volume":"175","author":"Groen","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ajog.2014.07.007_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-540-79090-7_4","article-title":"Afferent nerve regulation of bladder function in health and disease","volume":"194","author":"de Groat","year":"2009","journal-title":"Handb Exp Pharmacol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937814006899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937814006899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:59:23Z","timestamp":1757588363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937814006899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0002937814006899"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2014.07.007","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sacral nerve stimulation reduces elevated urinary nerve growth factor levels in women with symptomatic detrusor overactivity","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2014.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}